Stable angina pectoris of coronary heart disease treated with different acupuncture and moxibustion therapies: a network Meta-analysis.
10.13703/j.0255-2930.20220513-0002
- Author:
Ruo-Qi LI
1
,
2
;
Li WAN
1
,
3
;
Ming-Jie ZI
4
,
5
,
6
;
Wen-Hui DUAN
4
,
5
,
6
;
Li-Yun HE
7
;
Rong-Rong GAO
8
Author Information
1. Graduate School of Bejing University of CM, Beijing 100029, China
2. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091.
3. Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
4. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091
5. NMPA Key Laboratory for Clinical Research and Evaluation of TCM
6. National Clinical Research Center for Chinese Medicine Cardiology.
7. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences.
8. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700.
- Publication Type:Journal Article
- Keywords:
acupuncture and moxibustion;
coronary heart disease;
network Meta-analysis;
stable angina pectoris
- MeSH:
Humans;
Network Meta-Analysis;
Coronary Disease/therapy*
- From:
Chinese Acupuncture & Moxibustion
2022;42(12):1431-1438
- CountryChina
- Language:Chinese
-
Abstract:
To compare the clinical efficacy among different acupuncture and moxibustion therapies on stable angina pectoris (SAP) of coronary heart disease by means of network Meta-analysis. The articles of randomized controlled trial (RCT) for SAP of coronary heart disease treated with acupuncture and moxibustion therapies were searched from PubMed, Web of Science, Cochrane Library, CNKI, Wanfang database and VIP database from May 1, 2002 to May 1, 2022. The quality of them was assessed with the risk of bias assessment tool of Cochrane 5.3, and the network Meta-analysis was undertaken with Stata 13.1 software. A total of 29 articles were included with the acupuncture and moxibustion therapies involved, e.g. acupuncture, acupoint application and moxibustion. In comparison with the simple routine western medication, the effective rate was better on SAP treated with the combined treatments, in which, acupoint application, moxibustion, acupuncture and intradermal needling were combined with routine western medication (P<0.05). Of those combined treatments, the combination of the acupoint application with routine western medication had high probability, suggesting the optimal regimen (area under the curve [SUCRA]=0.711, P<0.05). The effective rate of acupuncture combined with routine western medication for ECG improvement was better than that of routine western medication (P<0.05), and such combined treatment was high in probability, underlying its optimal treatment (SUCRA=0.800, P<0.05). Combined with routine western medication, acupuncture, acupoint application, moxibustion and intradermal needling all improve the clinical efficacy on SAP of coronary heart disease. But, with different outcomes considered, the optimal treatments may be different. It needs more multi-central and large-sample randomized controlled trials to validate these results.
